NBIS
Nebius Group N.V.
There isn't enough reported data to score NBIS yet.
UCL
uCloudlink Group Inc.
UCL lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
NBIS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
UCL Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Weak | |
| Strong |
UCL's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
NBIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 68x | $22.45 | -83% |
| Fair | 114x | $37.67 | -71% |
| Current | 390x | $129 | — |
| Expensive | 666x | $220 | +71% |
Historical ranges are pointers, not guarantees.
NBIS's PE is 390x, but its earnings don't support one, so it isn't a reliable read right now.
UCL PE Valuation
UCL has no meaningful PE right now: it lost money over the past year.
NBIS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect NBIS's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.
UCL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| High |
UCL has the edge over NBIS on the outlook, with more favorable earnings expectations.
NBIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.33 | +$2.61 |
| Q4 2024 | -$2.28 | -456% |
| Q4 2023 | $0.64 | -36% |
| Q4 2022 | $1.00 | +$1.49 |
| Q4 2021 | -$0.49 | -156% |
| Q4 2020 | $0.87 | +89% |
| Q4 2019 | $0.46 | -73% |
| Q4 2018 | $1.71 | +434% |
NBIS has returned to profit: it earned $0.33 per share over the past year, after losing money the year before.
UCL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2024 | $0.12 | +$0.27 |
| Q1 2024 | $0.03 | +$0.36 |
| Q4 2023 | $0.08 | +$0.74 |
| Q3 2023 | $0.10 | +$1.27 |
| Q2 2023 | -$0.15 | +$1.12 |
| Q1 2023 | -$0.33 | +$1.02 |
| Q4 2022 | -$0.66 | +$0.96 |
| Q3 2022 | -$1.17 | +$0.35 |
UCL has the edge over NBIS in the latest year-over-year earnings comparison.
NBIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $9.7B | +53% |
| Q4 2022 | $6.3B | +46% |
| Q4 2021 | $4.3B | +63% |
| Q4 2020 | $2.6B | +24% |
| Q4 2019 | $2.1B | +37% |
| Q4 2018 | $1.5B | +36% |
| Q4 2017 | $1.1B | +24% |
| Q4 2016 | $917M | +27% |
NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -115% | -112 points |
| Q4 2023 | 3.6% | -11 points |
| Q4 2022 | 2.5% | -14 points |
| Q4 2021 | -3.7% | -18 points |
| Q4 2020 | 7.4% | -9.5 points |
| Q4 2019 | 14% | -2 points |
| Q4 2018 | 16% | -14 points |
| Q4 2017 | 14% | -19 points |
NBIS's operating margin was −115% last quarter, down 123 points from the same quarter a year ago, near the bottom of its range since 2011.
UCL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $18.2M | -5.9% |
| Q1 2026 | $16.9M | -10% |
| Q4 2025 | $22.3M | -14% |
| Q3 2025 | $21.2M | -16% |
| Q2 2025 | $19.4M | -13% |
| Q1 2025 | $18.7M | +3.4% |
| Q4 2024 | $26M | +19% |
| Q3 2024 | $25.2M | +5.6% |
UCL has the edge over NBIS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -16% | -20 points |
| Q1 2026 | -16% | -13 points |
| Q4 2025 | 8.5% | +15 points |
| Q3 2025 | 0.6% | -13 points |
| Q2 2025 | 4.2% | -5.9 points |
| Q1 2025 | -2.5% | -5.3 points |
| Q4 2024 | -6.6% | +1.9 points |
| Q3 2024 | 13% | -0.7 points |
UCL's operating margin was −16% last quarter, down 20 points from the same quarter a year ago.
NBIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7B | -$3.1B |
| Q4 2024 | -$562.1M | -$316.2M |
| Q4 2023 | -$245.9M | -$138.9M |
| Q4 2022 | -$107M | +$319.7M |
| Q4 2021 | -$426.7M | -539% |
| Q4 2020 | $97.3M | -66% |
| Q4 2019 | $287.9M | +$289.2M |
| Q4 2018 | -$1.3M | -101% |
NBIS has burned cash in six of the last eight quarters: −$4.6B over the past year, against −$43M the year before.
UCL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.1M | -$2M |
| Q1 2026 | -$8.7M | -$8.7M |
| Q4 2025 | $4.4M | +$7.8M |
| Q3 2025 | -$1.4M | -170% |
| Q2 2025 | -$1.1M | -135% |
| Q1 2025 | -$64K | -105% |
| Q4 2024 | -$3.5M | -$80K |
| Q3 2024 | $2M | +1.2% |
UCL has burned cash in six of the last eight quarters: −$9M over the past year, against −$3M the year before.
NBIS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -33.3M shares |
| 1 year | -32% | -115M shares |
| 3 years | -26% | -86.9M shares |
NBIS has the edge over UCL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $10M |
| Q4 2021 | $84.1M |
| Q4 2020 | $122.8M |
| Q4 2019 | $17.2M |
| Q4 2018 | $121.8M |
| Q4 2014 | $101.7M |
| Q4 2013 | $102.9M |
UCL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +163K shares |
| 1 year | +1.3% | +478K shares |
| 3 years | +33% | +9.3M shares |
| 5 years | +44% | +11.6M shares |
UCL has 38M diluted shares, up 1.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NBIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.7x | Very low |
| Q4 2022 | -0.7x | Net Cash |
NBIS's net debt is less than a year of its operating earnings (EBITDA).
UCL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -3.1x | Net Cash |
| Q1 2026 | -2.1x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -1.8x | Net Cash |
| Q2 2025 | -4.0x | Net Cash |
| Q2 2024 | -3.4x | Net Cash |
| Q1 2024 | -7.9x | Net Cash |
| Q4 2023 | -4.4x | Net Cash |
UCL has more cash than debt.
NBIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 8.3 | Oversold |
NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
UCL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 19.1 | Oversold |
| Stochastic | 4.7 | Oversold |
UCL's weekly RSI is 19 (oversold) and its Stochastic is 5 (oversold).
NBIS PE vs Communication Services Sector
| Metric | NBIS | Sector median | Relative |
|---|---|---|---|
| PE | 390x | 16x | 2,264% above |
| PE % | 62 | 24 | 38 pts above |
NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
UCL PE vs Communication Services Sector
| Metric | UCL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 16x | — |
UCL has no meaningful PE right now: it lost money over the past year.
NBIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.7 | 28% below |
| 20 week MA | $199.9 | 36% below |
| 50 week MA | $163.5 | 21% below |
| 100 week MA | $110.0 | 17% above |
NBIS has stronger trend alignment. NBIS is above 1 of 4 weekly averages versus UCL above 0 of 5.
UCL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.25 | 12% below |
| 20 week MA | $0.50 | 56% below |
| 50 week MA | $1.07 | 79% below |
| 100 week MA | $1.49 | 85% below |
| 200 week MA | $1.90 | 88% below |
UCL is in a downtrend: it's below all five of its weekly moving averages, and 88% below its 200-week average.
NBIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.6 | $27.3 | +40% |
| 2025 | $27.3 | $87.6 | +221% |
| 2026 YTD | $87.6 | $128.6 | +47% |
NBIS has the edge over UCL on returns for 2026, with the stronger performance.
UCL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.5 | $10.4 | -37% |
| 2021 | $10.4 | $3.30 | -68% |
| 2022 | $3.30 | $3.97 | +20% |
| 2023 | $3.97 | $1.75 | -56% |
| 2024 | $1.75 | $2.40 | +37% |
| 2025 | $2.40 | $2.05 | -15% |
| 2026 YTD | $2.05 | $0.22 | -89% |
UCL has finished lower in four of the last six years. It's down 89% so far in 2026.